Cargando…
Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is expressed in most human cell types (example: Epithelial cells, fibroblasts and endothelial), it serves a key role in the control of cell survival, proliferation and motility. The abnormal expression of FAK has been associated with...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507456/ https://www.ncbi.nlm.nih.gov/pubmed/31186683 http://dx.doi.org/10.3892/ol.2019.10147 |
_version_ | 1783417029955420160 |
---|---|
author | Nolasco-Quiroga, Manuel Rosas-Díaz, Marisol Moreno, José Godínez-Aguilar, Ricardo López-Ibarra, María José Piña-Sánchez, Patricia Alvarado-Cabrero, Isabel Vázquez-Gómez, Gerardo Rocha-Zavaleta, Leticia Arenas-Aranda, Diego Salamanca-Gómez, Fabio |
author_facet | Nolasco-Quiroga, Manuel Rosas-Díaz, Marisol Moreno, José Godínez-Aguilar, Ricardo López-Ibarra, María José Piña-Sánchez, Patricia Alvarado-Cabrero, Isabel Vázquez-Gómez, Gerardo Rocha-Zavaleta, Leticia Arenas-Aranda, Diego Salamanca-Gómez, Fabio |
author_sort | Nolasco-Quiroga, Manuel |
collection | PubMed |
description | Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is expressed in most human cell types (example: Epithelial cells, fibroblasts and endothelial), it serves a key role in the control of cell survival, proliferation and motility. The abnormal expression of FAK has been associated with poor prognosis in cancer, including ovarian cancer. However, although FAK isoforms with specific molecular and functional properties have been characterized, there are a limited number of published studies that examine FAK isoforms in ovarian cancer. The aim of the present study was to analyze the expression level of FAK and its isoforms in ovarian cancer. The expression of FAK kinase and focal adhesion targeting (FAT) domains was determined with immunohistochemistry in healthy ovary, and serous and mucinous cystadenoma, borderline tumor and carcinoma samples. Additionally, the expression of FAK and its isoforms were investigated in three ovarian cancer-derived cell lines with western blotting and reverse transcription-semi-quantitative polymerase chain reaction. An increased expression of FAK kinase domain was determined in serous tumor samples and was associated with advancement of the lesion. FAK kinase domain expression was moderate-to-low in mucinous tumor samples. The expression of the FAK FAT domain in tumor samples was reduced, compared with healthy ovary samples; however, the FAT domain was localized to the cellular nucleus. Expression of alternative transcripts FAK°, FAK(28,6) and FAK(28) was determined in all three cell lines investigated. In conclusion, FAK kinase and FAT domains are differentially expressed among ovarian tumor types. These results indicated the presence of at least two isoforms of FAK (FAK and the putative FAK-related non-kinase) in tumor tissue, which is supported by the cells producing at least three FAK alternative transcripts. These results may support the use of FAK and its isoforms as biomarkers for ovarian cancer. |
format | Online Article Text |
id | pubmed-6507456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-65074562019-06-11 Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer Nolasco-Quiroga, Manuel Rosas-Díaz, Marisol Moreno, José Godínez-Aguilar, Ricardo López-Ibarra, María José Piña-Sánchez, Patricia Alvarado-Cabrero, Isabel Vázquez-Gómez, Gerardo Rocha-Zavaleta, Leticia Arenas-Aranda, Diego Salamanca-Gómez, Fabio Oncol Lett Articles Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is expressed in most human cell types (example: Epithelial cells, fibroblasts and endothelial), it serves a key role in the control of cell survival, proliferation and motility. The abnormal expression of FAK has been associated with poor prognosis in cancer, including ovarian cancer. However, although FAK isoforms with specific molecular and functional properties have been characterized, there are a limited number of published studies that examine FAK isoforms in ovarian cancer. The aim of the present study was to analyze the expression level of FAK and its isoforms in ovarian cancer. The expression of FAK kinase and focal adhesion targeting (FAT) domains was determined with immunohistochemistry in healthy ovary, and serous and mucinous cystadenoma, borderline tumor and carcinoma samples. Additionally, the expression of FAK and its isoforms were investigated in three ovarian cancer-derived cell lines with western blotting and reverse transcription-semi-quantitative polymerase chain reaction. An increased expression of FAK kinase domain was determined in serous tumor samples and was associated with advancement of the lesion. FAK kinase domain expression was moderate-to-low in mucinous tumor samples. The expression of the FAK FAT domain in tumor samples was reduced, compared with healthy ovary samples; however, the FAT domain was localized to the cellular nucleus. Expression of alternative transcripts FAK°, FAK(28,6) and FAK(28) was determined in all three cell lines investigated. In conclusion, FAK kinase and FAT domains are differentially expressed among ovarian tumor types. These results indicated the presence of at least two isoforms of FAK (FAK and the putative FAK-related non-kinase) in tumor tissue, which is supported by the cells producing at least three FAK alternative transcripts. These results may support the use of FAK and its isoforms as biomarkers for ovarian cancer. D.A. Spandidos 2019-06 2019-03-15 /pmc/articles/PMC6507456/ /pubmed/31186683 http://dx.doi.org/10.3892/ol.2019.10147 Text en Copyright: © Nolasco-Quiroga et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Nolasco-Quiroga, Manuel Rosas-Díaz, Marisol Moreno, José Godínez-Aguilar, Ricardo López-Ibarra, María José Piña-Sánchez, Patricia Alvarado-Cabrero, Isabel Vázquez-Gómez, Gerardo Rocha-Zavaleta, Leticia Arenas-Aranda, Diego Salamanca-Gómez, Fabio Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title | Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title_full | Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title_fullStr | Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title_full_unstemmed | Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title_short | Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer |
title_sort | increased expression of fak isoforms as potential cancer biomarkers in ovarian cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507456/ https://www.ncbi.nlm.nih.gov/pubmed/31186683 http://dx.doi.org/10.3892/ol.2019.10147 |
work_keys_str_mv | AT nolascoquirogamanuel increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT rosasdiazmarisol increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT morenojose increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT godinezaguilarricardo increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT lopezibarramariajose increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT pinasanchezpatricia increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT alvaradocabreroisabel increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT vazquezgomezgerardo increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT rochazavaletaleticia increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT arenasarandadiego increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer AT salamancagomezfabio increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer |